Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Dermatology

Can Folliculitis Decalvans Scars Turn Into Skin Cancer?

At a Glance

Squamous cell skin cancer has been reported in long-standing Quinquaud folliculitis decalvans scars, but it appears uncommon and the exact risk is unknown. A new growing lump, non-healing sore, bleeding, unusual growth, or deep pain needs dermatologist evaluation and may require biopsy.

Squamous cell skin cancer (SCC) developing in long-standing Quinquaud folliculitis decalvans (FD) scars has been reported in the medical literature, but it is uncommon [1]. The true risk of this happening has not been quantified, and there are only a small number of published cases [1]. However, because skin cancer can sometimes occur in areas of chronic inflammation and scarring, it is important to know which skin changes require prompt medical assessment rather than assuming every change is just another FD flare [2].

Why Cancer Can Form in Scar Tissue

Skin that has been inflamed or scarred for many years—often decades—can undergo changes that increase the risk of malignant (cancerous) cells developing. When a squamous cell carcinoma develops in an area of long-standing scarring or a chronic wound, doctors sometimes use the historical term Marjolin ulcer.

In people with scarring hair-loss conditions like FD, prolonged inflammation, long-term exposure of the bare scalp to ultraviolet (UV) rays, and the use of certain immunosuppressive medications are proposed as general risk factors for skin cancer in scars [2]. However, evidence directly linking these factors to SCC specifically in FD is limited [2]. Having FD does not mean you will inevitably get skin cancer [1]. You should continue any prescribed immunosuppressive treatments unless your doctor tells you to stop.

Distinguishing Normal FD from Warning Signs

Quinquaud folliculitis decalvans is known for causing cycles of scalp inflammation. Most pustules, crusting, and tenderness in FD are simply inflammatory [3]. Typical symptoms of an FD flare include recurrent pus-filled bumps (pustules), redness, crusting, tufts of hair, itching, and pain [4].

Because these symptoms are expected, spotting a new problem requires looking for changes that are distinctly different from your usual pattern. Contact your dermatologist within a few days if you notice:

  • A persistent or enlarging discrete lump: A new, firm mass that continues to grow rather than resolving like a typical pustule [5][6].
  • A sore that won’t heal: A persistent open wound (ulceration) that does not heal over several weeks [5][7].
  • Unusual bleeding or hemorrhagic crusting: A spot that bleeds easily or forms unusual, bloody crusts [6][8].
  • Exophytic tissue: Fleshy growths that stick out from the skin surface [6][8].
  • Escalating or deep localized pain: A sudden change in the type or intensity of pain, or a lump that feels deeply tender or fixed to the tissue below [5].

Note: Some of these signs, such as foul-smelling drainage, crusting, and increased pain, can also happen with a bacterial infection or a severe FD flare [8]. Seeing these warning signs does not mean you definitely have cancer, but they do require a medical evaluation to be sure.

When to seek urgent care: If you experience uncontrolled bleeding, rapidly spreading swelling, fever, or feel acutely unwell, seek urgent medical care immediately.

What to Do If You Spot a Warning Sign

If you notice any of these signs, do not rely only on your routine FD treatments, and do not delay an examination. Do not start applying new medications to cover the lesion, and ask your prescribing clinician whether to continue your current medicines until your exam [9].

Because SCC and FD inflammation can look similar or happen at the same time, a visual exam alone is not always enough [10]. To confirm a diagnosis, your doctor will likely perform a skin biopsy, removing a small sample of the tissue (usually under local anesthetic) to be examined under a microscope [9].

The dermatologist will choose the biopsy method (such as a shave, punch, or surgical excision) based on the lesion’s appearance [11]. Sometimes, deeper samples are needed to assess abnormal cells hidden in the scar [12][13]. If a spot continues to look suspicious but an initial biopsy does not show cancer, your doctor may recommend a repeat biopsy or removing the lesion entirely [10].

Monitoring Your Scalp

Because SCC in FD is so uncommon, there is no established, FD-specific screening schedule for skin cancer. Follow-up frequency depends on your specific symptoms, the duration of your FD, your UV exposure, and other personal risk factors.

Between appointments, check accessible areas of your scalp periodically. You can use photographs or ask a trusted person to inspect hard-to-see areas. To protect your scarred scalp from UV damage, wear a protective hat and use broad-spectrum sunscreen on intact skin; avoid putting sunscreen on open or actively draining wounds unless advised by your doctor [2].

Common questions in this guide

Can folliculitis decalvans scars develop squamous cell skin cancer?
Yes. Squamous cell carcinoma has been reported in long-standing folliculitis decalvans scars, but it appears uncommon, and the true risk has not been quantified. Having folliculitis decalvans does not mean that you will inevitably develop skin cancer.
Which changes in an FD scar need a dermatologist’s attention?
A new firm lump that grows, a sore that does not heal over several weeks, easy bleeding or bloody crusting, a fleshy growth, or a sudden change to deeper or more intense pain should be assessed promptly. These findings can also result from infection or a severe FD flare, so they do not prove cancer.
How is skin cancer diagnosed in a folliculitis decalvans scar?
A dermatologist usually examines the area and performs a skin biopsy, removing a small tissue sample for examination under a microscope. Depending on the lesion, the biopsy may be a shave, punch, or excision; a deeper or repeat biopsy may be needed if suspicion remains.
Does every non-healing sore on an FD scar mean cancer?
No. A persistent sore can also be related to infection or severe folliculitis decalvans inflammation, but an open wound that does not heal over several weeks should be medically assessed rather than treated as an ordinary flare.
Is there a recommended skin cancer screening schedule for folliculitis decalvans?
There is no established FD-specific screening schedule because cancer in FD scars is uncommon and the risk is not well quantified. Your dermatologist can tailor follow-up to your symptoms, how long you have had FD, UV exposure, and other personal risk factors.
Should I stop my FD medication if a suspicious scalp spot appears?
Do not stop prescribed immunosuppressive treatment unless the clinician who prescribed it tells you to do so. Contact that clinician about how to handle your medicines while the lesion is being examined, and do not cover the spot with a new medication without advice.

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Squamous cell carcinoma originating in folliculitis decalvans.

    Luu Y, Kimmis BD, Pulumati A, et al.

    Dermatology online journal 2025; (31(1)) doi:10.5070/D331164986.

    PMID: 40526940
  2. 2

    Scarring Alopecia and Risk of Skin Cancer: A Literature Review.

    Lee J, de Gregorio L, Tosti A

    Skin appendage disorders 2025; 1-8 doi:10.1159/000545345.

    PMID: 40330854
  3. 3

    Non-invasive Assessment and Management of Folliculitis Decalvans by Trichoscopy and Reflectance Confocal Microscopy.

    Piscazzi F, Franceschini C, Narcisi A, et al.

    Dermatology practical & conceptual 2024; (14(3)) doi:10.5826/dpc.1403a167.

    PMID: 39122540
  4. 4

    Successful Treatment with Fusidic Acid in a Patient with Folliculitis Decalvans.

    Pimenta R, Borges-Costa J

    Acta dermatovenerologica Croatica : ADC 2019; (27(1)):49-50.

    PMID: 31032795
  5. 5

    Squamous Cell Carcinoma Scalp With Intracranial Extension: Challenging Case of Multidisciplinary Care.

    Chirukandath R, Krishnan SK, Sulaiman SV, et al.

    Cureus 2023; (15(2)):e34975 doi:10.7759/cureus.34975.

    PMID: 36938224
  6. 6

    Giant neglected cutaneous squamous cell carcinoma of the scalp with full-thickness calvarial erosion and early fatal outcome: CT findings and treatment-planning implications.

    El Hassani N, Amar S, Jroundi L, El Aoufir O

    Radiology case reports 2026; (21(12)):6257-6261 doi:10.1016/j.radcr.2026.09.007.

    PMID: 42827682
  7. 7

    Incidences of malignancy in chronic burn scar ulcers: experience from Bangladesh.

    Das KK, Chakaraborty A, Rahman A, Khandkar S

    Burns : journal of the International Society for Burn Injuries 2015; (41(6)):1315-21.

    PMID: 25716761
  8. 8

    Invasive Cutaneous Squamous Cell Carcinoma Arising from Chronic Hidradenitis Suppurativa: A Case Report of Treatment by Slow Mohs Micrographic Surgery.

    Lee SJ, Lim JM, Lee SH, et al.

    Annals of dermatology 2021; (33(1)):68-72 doi:10.5021/ad.2021.33.1.68.

    PMID: 33911814
  9. 9

    Non-invasive diagnostic techniques in the diagnosis of squamous cell carcinoma.

    Warszawik-Hendzel O, Olszewska M, Maj M, et al.

    Journal of dermatological case reports 2015; (9(4)):89-97 doi:10.3315/jdcr.2015.1221.

    PMID: 26848316
  10. 10

    Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans.

    Ding L, DeGiovanni JC, Bogner P, Soofi Y

    BMJ case reports 2022; (15(3)) doi:10.1136/bcr-2021-247932.

    PMID: 35260404
  11. 11

    Basal Cell and Cutaneous Squamous Cell Carcinomas: Diagnosis and Treatment.

    Firnhaber JM

    American family physician 2020; (102(6)):339-346.

    PMID: 32931212
  12. 12

    Histopathological Diagnostic Discordance between Punch Biopsies and Final Diagnostic Excisions of Cutaneous Squamous Cell Carcinoma: Analysis of 737 Cases.

    Hopkins K, Ingvar Å, Palmgren J, et al.

    Acta dermato-venereologica 2025; (105()):adv40727 doi:10.2340/actadv.v105.40727.

    PMID: 39749387
  13. 13

    Correlation between histological findings on punch biopsy specimens and subsequent excision specimens in cutaneous squamous cell carcinoma.

    Westers-Attema A, Joosten VM, Roozeboom MH, et al.

    Acta dermato-venereologica 2015; (95(2)):181-5 doi:10.2340/00015555-1826.

    PMID: 24556935

This page is for informational purposes only and does not constitute medical advice about folliculitis decalvans or skin cancer risk. A dermatologist should assess any persistent, changing, bleeding, or non-healing scalp lesion.